The Recall Desk

Hazard

Potency Issues recalls

4 recalls in our database tag this hazard, drawn from FDA, USDA FSIS, CPSC, and NHTSA source notices.

What the numbers show

Total
4
Critical
0
Severe
2
Most recent
2018-07-11

Of the 4 potency issues recalls we have scored against our rubric, 0 (0%) are Critical — deaths or serious injuries reported, or the agency’s own highest classification — and 2 (50%) are Severe.

About this hazard tag

Hazard tags are short, machine-readable labels we attach to every recall to make cross-cutting queries possible — “all potency issues recalls regardless of agency”, “all listeria recalls in California”, “all airbag recalls in 2025”. The tags are extracted from each recall’s source text during the LLM rewrite step and validated against a fixed schema.

A recall can carry multiple tags — a Listeria recall might also be tagged ready-to-eat and undeclared-allergen. Use the full-text search if you want to combine hazard tags with brand or category filters.

1–4 of 4

  • SevereFDA (Drugs)·D-0890-2018·2018-07-11

    Ingenus Recalls Irinotecan Hydrochloride Injection Due to Potency Issues

    Ingenus Pharmaceuticals is recalling specific lots of Irinotecan Hydrochloride Injection because they had high out-of-specification assay values for potency.

    Product
    IRINOTECAN HYDROCHLORIDE — IRINOTECAN HYDROCHLORIDE (IRINOTECAN HYDROCHLORIDE)
    Category
    Drug
    Distribution
    Distributed nationwide
  • LowFDA (Drugs)·D-0471-2017·2017-02-15

    Apotex Recalls Aripiprazole Tablets Due to Potential Potency Issues

    Apotex Inc. is recalling 67,946 bottles of 2 mg Aripiprazole tablets because the product may not meet specifications throughout its shelf life.

    Product
    Aripiprazole Tablets, 2 mg, 30-count bottle, Rx only, Manufactured by: Apotex Inc., Toronto, Ontario, Canada, M9L 1T9; Manufactured for: Apotex Corp., Weston, Florida 33326, NDC 60505-3075-3.
    Category
    Drug
    Distribution
    Distributed nationwide
  • ModerateFDA (Drugs)·D-0129-2017·2016-11-16

    Wells Pharmacy Recalls Testosterone Pellets Due to Potency Issues

    Wells Pharmacy Network is recalling Testosterone 12.5 mg Pellets because they were found to be superpotent or subpotent.

    Product
    Testosterone 12.5 mg Pellet, Compounded by: Wells Pharmacy Network
    Category
    Drug
    Distribution
    0 states